share_log
Breakings ·  Jun 7 11:35
Seres Therapeutics Inc : Chardan Capital Markets Cuts Target Price to $1.25 From $6
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment